Xenon Pharmaceuticals Inc. Quarterly Operating Income (Loss) in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Xenon Pharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2013 to Q3 2024.
  • Xenon Pharmaceuticals Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$73.7M, a 32.3% decline year-over-year.
  • Xenon Pharmaceuticals Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$256M, a 25.4% decline year-over-year.
  • Xenon Pharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$214M, a 65.8% decline from 2022.
  • Xenon Pharmaceuticals Inc. annual Operating Income (Loss) for 2022 was -$129M, a 63.5% decline from 2021.
  • Xenon Pharmaceuticals Inc. annual Operating Income (Loss) for 2021 was -$79M, a 152% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$256M -$73.7M -$18M -32.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$238M -$69.1M -$13.5M -24.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$224M -$59M -$9.99M -20.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$214M -$53.7M -$10.4M -23.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$204M -$55.7M -$17.6M -46% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$186M -$55.6M -$25.3M -83.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$161M -$49.1M -$31.7M -182% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$129M -$43.3M -$18.5M -74.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$111M -$38.1M -$22.5M -144% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$88.1M -$30.3M -$7.82M -34.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$80.3M -$17.4M -$1.31M -8.16% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$79M -$24.8M -$11.9M -92.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$67.1M -$15.6M -$5.9M -60.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$61.2M -$22.5M -$21.9M -3383% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$39.3M -$16.1M -$8.03M -99.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$31.3M -$12.9M -$1.33M -11.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$30M -$9.7M -$748K -8.36% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$29.2M -$646K +$9.87M +93.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$39.1M -$8.03M +$3.73M +31.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$42.8M -$11.6M -$3.14M -37.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$39.7M -$8.95M +$5.24M +36.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$44.9M -$10.5M -$2.92M -38.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$42M -$11.8M -$3.95M -50.6% Jan 1, 2019 Mar 31, 2019 10-Q/A 2020-05-26
Q4 2018 -$38M -$8.45M -$403K -5.01% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-09
Q3 2018 -$37.6M -$14.2M -$5.54M -64.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$32.1M -$7.59M +$299K +3.79% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 -$32.4M -$7.81M +$181K +2.27% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$32.6M -$8.05M -$2.59M -47.4% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-07
Q3 2017 -$30M -$8.64M -$1.31M -17.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$28.7M -$7.89M -$1.53M -24% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$27.1M -$7.99M -$2.33M -41.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$24.8M -$5.46M -$2.86M -110% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$22M -$7.33M -$6.51M -794% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-07
Q2 2016 -$15.4M -$6.37M -$6.57M -3299% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-07
Q1 2016 -$8.88M -$5.66M +$479K +7.81% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-07
Q4 2015 -$9.36M -$2.6M -$2.64M -7537% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-08
Q3 2015 -$6.72M -$820K -$9.48M -109% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-08
Q2 2015 $2.76M $199K -$1.18M -85.6% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-08
Q1 2015 $3.94M -$6.14M -$7.17M -695% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-08
Q4 2014 $11.1M $35K -$1.98M -98.3% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-08
Q3 2014 $13.1M $8.66M +$2.14M +32.9% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-08
Q2 2014 $10.9M $1.38M +$2.15M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-08
Q1 2014 $8.8M $1.03M -$912K -46.9% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-08
Q4 2013 $9.71M $2.02M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-12
Q3 2013 $6.52M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-12
Q2 2013 -$770K Apr 1, 2013 Jun 30, 2013 10-K 2015-03-12
Q1 2013 $1.94M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.